Viewing Study NCT03140332


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-01-22 @ 3:56 PM
Study NCT ID: NCT03140332
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2017-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
Sponsor: Centre Hospitalier Universitaire, Amiens
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-02-27
Start Date Type: ACTUAL
Primary Completion Date: 2020-02-27
Primary Completion Date Type: ACTUAL
Completion Date: 2020-02-27
Completion Date Type: ACTUAL
First Submit Date: 2017-04-27
First Submit QC Date: None
Study First Post Date: 2017-05-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-07-17
Last Update Post Date: 2020-07-20
Last Update Post Date Type: ACTUAL